Back

FonLiver risk score in patients with tricuspid regurgitation: a 10-year prospective cohort study

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Tricuspid valve disease and heart failure Tricuspid Valve Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Jingnan Zhang

University of Hong Kong-Shenzhen Hospital, Shenzhen (China)

5 More presentations in this session

Presentation thumbnail
Association of pressure-adjusted heart rate with heart failure and long-term mortality in patients with significant tricuspid valve regurgitation
Mr C. Kane (Dublin, IE)
Abstract
Presentation thumbnail
Definition and prognosis of tricuspid regurgitation in transthyretin amyloid cardiomyopathy: a multicentre international cohort study
Doctor L. Hauptmann (Vienna, AT)
Abstract
Presentation thumbnail
Regurgitant fraction by 3DE: outcome-based grading of secondary tricuspid regurgitation across atrial and ventricular phenotypes
Doctor A. Buta (Bucharest, RO)
Abstract
Presentation thumbnail
More than size: right atrial cardiomyopathy mechanistic insights in atrial functional tricuspid regurgitation
Mr E. Gunawan (Barcelona, ES)
Abstract
Presentation thumbnail
Liver-related outcomes in patients with tricuspid regurgitation
Mr J. Zhang (Shenzhen, CN)
Abstract

Access the full session

Session thumbnail
Tricuspid valve disease and heart failure

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
ESC Journals
TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation
25 August 2023
thumbnail
Congress Presentation
Framingham risk score associates with incident cancer and heart failure
21 June 2025
thumbnail
Congress Presentation
Patients with Fontan circulation beyond the fourth decade of life
31 August 2020
thumbnail
Congress Presentation
Predictability of noninvasive liver fibrosis score for cardiac events in patients with nonalcoholic fatty liver disease
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources